Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neuronetics Inc STIM

Healthcare Medical Devices
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength... see more

Recent & Breaking News (NDAQ:STIM)

Neuronetics Announces Strategic Leadership Promotions to Support Future Growth

GlobeNewswire February 11, 2021

Neuronetics to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire February 10, 2021

Neuronetics Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

GlobeNewswire February 2, 2021

Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock

GlobeNewswire January 28, 2021

Neuronetics Announces Proposed Public Offering of Common Stock

GlobeNewswire January 28, 2021

NeuroStar® Advanced Therapy's Depression Outcomes Registry Hits 10,000 Patient Milestone

GlobeNewswire January 19, 2021

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results

GlobeNewswire January 12, 2021

Neuronetics to Participate at the 23rd Annual ICR Westwicke Conference

GlobeNewswire January 7, 2021

Neuronetics Announces Expansion of Sales Organization

GlobeNewswire January 7, 2021

Neuronetics Announces the Amendment of Credit Facility with Solar Capital Partners

GlobeNewswire December 8, 2020

Neuronetics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

GlobeNewswire November 30, 2020

Neuronetics® Receives FDA Clearance for Three-Minute TouchStar(TM) Treatment Protocol

GlobeNewswire November 23, 2020

Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum

GlobeNewswire November 12, 2020

Neuronetics Reports Third Quarter 2020 Financial and Operating Results

GlobeNewswire November 2, 2020

Neuronetics to Report Third Quarter 2020 Financial and Operating Results and Host Conference Call

GlobeNewswire October 19, 2020

Journal of Affective Disorders Publishes Clinical Data Suggesting NeuroStar® Advanced Therapy as a First-line Treatment for Major Depressive Disorder

GlobeNewswire October 13, 2020

Neuronetics Appoints Sara Grubbs as Vice President, Sales

GlobeNewswire October 5, 2020

NeuroStar® Advanced Therapy Providers Offer Free TMS Consultations During National Depression Awareness Month

GlobeNewswire October 1, 2020

Neuronetics® Celebrates 500,000 Treatment Milestone for Greenbrook® TMS

GlobeNewswire September 29, 2020

Neuronetics Unveils New Depression Data at Clinical TMS Society's Virtual Events

GlobeNewswire September 22, 2020